SGO

Gottfried Konecny, MD

Shifting the MIRV Timeline

New study highlights the possibilities of MIRV plus carboplatin in platinum-sensitive ovarian cancer.

Abigail Zamorano, MD, MPHS (left), and Julie Sammouri, MD

Cost-Saving and High Impact Primary HPV Testing

SISTER: All for one and one for all?

Getty Images 2188501555

Save the date for SGO 2027 Annual Meeting on Women's Cancer

Emily O'Brien, MD

A Clearer Signal in Ovarian Cancer

Screenshot 2026 04 11 At 7 18 33 Am

Watch | SGO 2026 Annual Meeting Opening Ceremony

Advancing Science. Empowering Teams. Embracing Change.

Kelsey Wood (left) and Kim Hoarle, MBA, CAE

Where Science Meets Community

Shared exhibit space at the SGO booth brings clinicians, researchers, and advocates together to tell the full story of gynecologic oncology.

Step into new possibilities

Step into new possibilities

Learn about a targeted treatment that could make a difference for your patients.

Dsc02155 (1)

Smile, You’re on Camera!

See Photo Gallery

ROSELLA Trial: Beyond Biomarkers

Trial results suggest a new standard in platinum-resistant ovarian cancer (PROC) therapy.

Amanda Nickles Fader, MD

Chemotherapy Followed by Endocrine Therapy Continues for Treatment of Low Grade Serous Ovarian Cancer

New science addresses a key clinical question about treating advanced-stage LGSOC.

Explore our DXd ADC Technology

Explore our DXd ADC Technology

Step into new possibilities

Step into new possibilities

Click here to learn more about Avmapki Fakzynja Co-Pack

Click here to learn more about Avmapki Fakzynja Co-Pack

Karen Lu, MD

Welcome to the SGO 2026 Annual Meeting on Women’s Cancer

SGO President Karen Lu, MD, reveals the three key components of this year’s theme.

Sgo26 Awards

SGO 2026 Awards

High-caliber individuals are recognized for their work in research and service.

See the Award Winners

Sgo26 Awards Researchand Donors

2026 Research Awards and Donor Appreciation

23 men and women recognized for their important contributions in research.

See the Award Winners

Matthew A. Powell, MD

Meet SGO Incoming President, Matthew A. Powell, MD

Dr. Powell shares more about his background, new role, and plans for the upcoming year.

Ana Oaknin, MD, PhD

One-Two Punch for Gynecologic Oncology

Antibody–drug conjugate shows promising response rates in difficult‑to‑treat ovarian and endometrial cancer.

Matthew A. Powell, MD

Hope on the Horizon

Phase 3 RUBY trial demonstrated positive outcomes for patients with primary advanced or recurrent endometrial cancer.

Sgo April 11th Selects 24

A Perfect Place to Lounge and Lean in

Oleksandra Dzyubak, MD

The Move Toward Personalized Fertility Sparing Treatment

Ginger J. Gardner, MD, FACOG

Building a Brighter Future

Madison Kieffer, MD (left), and Katelyn Tondo-Steele, DO

Can Artificial Intelligence Save Real Time?

Pamela T. Soliman, MD, MPH (left), and Christine Walsh, MD, MS

Breakthrough Science, Bold Conversations, and New Educational Experiences

Getty Images 1400275887

Accreditation and Evaluations for CE

Screenshot 2026 04 02 At 10 03 21 Am

Bill Cliby, MD, Accepts the President's Award

Screenshot 2026 03 31 At 9 41 47 Am

Empowering Teams in San Juan

Screenshot 2026 03 31 At 9 41 37 Am

Embracing Change in San Juan

Screenshot 2026 03 28 At 10 13 09 Am

Explore the SGO 2026 Annual Meeting Schedule

Screenshot 2026 03 28 At 9 42 23 Am

Advancing Science in San Juan

Sgo April 12th Selects 43

SGO 2026 Annual Meeting on Women’s Cancer Photo Gallery